Stellar Biotechnologies, Inc. (SBOTF) Reports Q3 2014 Financial Results and Corporate Update
Stellar Biotechnologies, a leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today reported its financial results for the third quarter and nine months ended May 31, 2014. It also provided a few operational highlights from that time frame as well. Financial Results: Cash Position: Cash and cash equivalents as of May 31, 2014 were $14.8 million, compared to $ 7.9 million at year-end August 31, 2013. The Company believes current cash will be sufficient to meet estimated working capital requirements and fund planned program development through 2015. During the nine months ended May 31, 2014, the Company received…